Foghorn Therapeutics Stock Market Value
| FHTX Stock | USD 7.90 0.06 0.77% |
| Symbol | Foghorn |
Foghorn Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Foghorn Therapeutics. If investors know Foghorn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Foghorn Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.85) | Revenue Per Share 0.513 | Quarterly Revenue Growth (0.55) | Return On Assets (0.20) | Return On Equity (4.70) |
The market value of Foghorn Therapeutics is measured differently than its book value, which is the value of Foghorn that is recorded on the company's balance sheet. Investors also form their own opinion of Foghorn Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Foghorn Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Foghorn Therapeutics' market value can be influenced by many factors that don't directly affect Foghorn Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Foghorn Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Foghorn Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Foghorn Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Foghorn Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Foghorn Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Foghorn Therapeutics.
| 12/07/2022 |
| 11/26/2024 |
If you would invest 0.00 in Foghorn Therapeutics on December 7, 2022 and sell it all today you would earn a total of 0.00 from holding Foghorn Therapeutics or generate 0.0% return on investment in Foghorn Therapeutics over 720 days. Foghorn Therapeutics is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting geneti... More
Foghorn Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Foghorn Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Foghorn Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.52 | |||
| Information Ratio | 0.0137 | |||
| Maximum Drawdown | 34.64 | |||
| Value At Risk | (6.81) | |||
| Potential Upside | 8.5 |
Foghorn Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Foghorn Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Foghorn Therapeutics' standard deviation. In reality, there are many statistical measures that can use Foghorn Therapeutics historical prices to predict the future Foghorn Therapeutics' volatility.| Risk Adjusted Performance | 0.0375 | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.66) | |||
| Sortino Ratio | 0.0165 | |||
| Treynor Ratio | 0.0586 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Foghorn Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Foghorn Therapeutics Backtested Returns
Foghorn Therapeutics appears to be slightly risky, given 3 months investment horizon. Foghorn Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0368, which denotes the company had a 0.0368% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Foghorn Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Foghorn Therapeutics' Mean Deviation of 4.06, downside deviation of 4.52, and Coefficient Of Variation of 2653.16 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Foghorn Therapeutics holds a performance score of 2. The firm shows a Beta (market volatility) of 3.33, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Foghorn Therapeutics will likely underperform. Please check Foghorn Therapeutics' downside variance, and the relationship between the total risk alpha and daily balance of power , to make a quick decision on whether Foghorn Therapeutics' price patterns will revert.
Auto-correlation | -0.55 |
Good reverse predictability
Foghorn Therapeutics has good reverse predictability. Overlapping area represents the amount of predictability between Foghorn Therapeutics time series from 7th of December 2022 to 2nd of December 2023 and 2nd of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Foghorn Therapeutics price movement. The serial correlation of -0.55 indicates that about 55.0% of current Foghorn Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.55 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 2.24 |
Foghorn Therapeutics lagged returns against current returns
Autocorrelation, which is Foghorn Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Foghorn Therapeutics' stock expected returns. We can calculate the autocorrelation of Foghorn Therapeutics returns to help us make a trade decision. For example, suppose you find that Foghorn Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Foghorn Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Foghorn Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Foghorn Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Foghorn Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Foghorn Therapeutics Lagged Returns
When evaluating Foghorn Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Foghorn Therapeutics stock have on its future price. Foghorn Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Foghorn Therapeutics autocorrelation shows the relationship between Foghorn Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Foghorn Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Foghorn Stock Analysis
When running Foghorn Therapeutics' price analysis, check to measure Foghorn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn Therapeutics is operating at the current time. Most of Foghorn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Foghorn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn Therapeutics' price. Additionally, you may evaluate how the addition of Foghorn Therapeutics to your portfolios can decrease your overall portfolio volatility.